首页> 美国卫生研究院文献>The Oncologist >Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX–Bevacizumab or FOLFIRI–Bevacizumab: Results From ARIES a Bevacizumab Observational Cohort Study

【2h】

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX–Bevacizumab or FOLFIRI–Bevacizumab: Results From ARIES a Bevacizumab Observational Cohort Study

机译：最初用FOLFOX-贝伐单抗或FOLFIRI-贝伐单抗治疗的转移性结直肠癌患者的治疗模式和临床结果：贝伐单抗观察性队列研究的ARIES结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background.The Avastin® Registry: Investigation of Effectiveness and Safety (ARIES) study is a prospective, community-based observational cohort study that evaluated the effectiveness and safety of first-line treatment patterns, assessing the impact of chemotherapy choice and treatment duration.

机译：背景：Avastin®注册机构：有效性和安全性调查（ARIES）研究是一项前瞻性，基于社区的观察性队列研究，评估了一线治疗模式的有效性和安全性，评估了化疗选择和治疗持续时间的影响。

著录项

期刊名称 The Oncologist
作者
Johanna C. Bendell; Tanios S. Bekaii-Saab; Allen L. Cohn; Herbert I. Hurwitz; Mark Kozloff; Haluk Tezcan; Nancy Roach; Yong Mun; Susan Fish; E. Dawn Flick; Darshan Dalal; Axel Grothey;
展开▼
作者单位

展开▼
年(卷),期 2012(17),12
年度 2012
页码 1486–1495
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Bevacizumab FOLFOX protocol FOLFIRI protocol Safety Treatment outcome;

机译：贝伐单抗;FOLFOX方案;FOLFIRI方案;安全性;治疗结果;

相似文献

外文文献
中文文献
专利

1. Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-Bevacizumab or FOLFIRI-bevacizumab: Results from ARIES, a bevacizumab observational cohort study [J] . BendellJ.C., Bekaii-SaabT.S., CohnA.L., The oncologist . 2012,第12期

机译：最初用FOLFOX-贝伐单抗或FOLFIRI-贝伐单抗治疗的转移性结直肠癌患者的治疗模式和临床结局：贝伐单抗观察性队列研究ARIES的结果
2. Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOXa??Bevacizumab or FOLFIRIa??Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study [J] . Johanna C. Bendell, Tanios S. Bekaii-Saab, Allen L. Cohn, The oncologist . 2012,第12期

机译：最初用FOLFOXa-贝伐单抗或FOLFIRIa-贝伐单抗治疗的转移性结直肠癌患者的治疗模式和临床结果：贝伐单抗观察性队列研究的ARIES结果
3. Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOXa??Bevacizumab or FOLFIRIa??Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study [J] . Johanna C. Bendell, Tanios S. Bekaii-Saab, Allen L. Cohn, The oncologist . 2012,第12期

机译：最初用FOLFOXa-贝伐单抗或FOLFIRIa-贝伐单抗治疗的转移性结直肠癌患者的治疗模式和临床结果：贝伐单抗观察性队列研究的ARIES结果
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme) [O] . Antonio Avallone, Maria Carmela Piccirillo, Luigi Aloj, 2016

机译：贝伐单抗与FOLFOX / OXXEL联合优化治疗转移性结直肠癌患者的3期随机研究-OBELICS（化学疗法方案中贝伐单抗方案的优化）
7. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial [O] . Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini, 2020

机译：Upfront folfoxiri加贝伐单抗和次曲后的重新引入与mfolfox6 plus bevacizumab，然后是Folfiri加Bevacizumab治疗转移性结肠直肠癌（Tribe2）：多期，开放标签，第3阶段，随机，受控试验

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX–Bevacizumab or FOLFIRI–Bevacizumab: Results From ARIES a Bevacizumab Observational Cohort Study

摘要

著录项

相似文献

相关主题

期刊订阅